BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Medical Marijuana, Inc. Reports Third Quarter 2012 Revenue and Income Quarter Over Quarter Increase Of Over 1500 Percent From Same Period Last Year


11/15/2012 10:07:09 AM

SAN DIEGO, Nov. 15, 2012 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), a leading cannabis and hemp industry innovator, today announced its third quarter earnings.  The company earned net income of approximately $1.19 million on gross revenues of $3.00 million for the quarter ended Sept 30, 2012.  This represents a gross revenue increase of 1500 plus percent quarter-over-quarter when compared to revenue of $198,813 for the quarter ended Sept 30, 2011.

Operational and development highlights

Operating highlights of the quarter were as follows:

  • Completed the integration of Dixie Elixirs & Edibles brand. Developed and launched the Dixie X, Hemp based CBD wellness products. Dixie X is now available for purchase online. The company has completed its wholesale product launch for the specialty cannabis and hemp retail markets in the US.
  • Launched Dixie X compassion care club.
  • Successfully planted and harvested its hemp crops for the production of its high value hemp CBD oil.
  • PhytoSPHERE Systems sold its first batch of commercialized hemp CBD Oil.
  • Expanded PhytoSPHERE systems production capabilities to meet 2013 supply demands for its CBD hemp oil.
  • Identified and developed additional cultivars to expand portfolio of high value hemp oils for deployment in 2013.
  • Completed integration of CanCHEW Bio-Technologies.
  • Produced CanCHEW Bio-Technologies first batch of marketable GMP manufactured CBD based over-the-counter (OTC) functional chewing gum.
  • CanCHEW Bio-Technologies identified European clinical development path for its patented cannabinoid based functional chewing gum. European clinical trials expected to begin 2013.
  • Formed Canipa Holdings, for European product expansion.
  • Identified several potential acquisition and investment opportunities in established cannabis and hemp based businesses.
  • Signed closing docs for Lotus Capital $2.0 million line of credit.
  • Negotiated additional $15.0 million institutional line of credit.

In addition, since the close of the third quarter, Medical Marijuana, Inc. has:

  • Produced over 365 million milligrams of hemp CBD oil for MJNA product sales.
  • Negotiated the purchase of key international hemp product development, manufacturing, sales and marketing brand with 30 plus consumer products in market today. Expected to close 4 Q 2012.
  • PhytoSPHERE Systems has expanded its portfolio of products to include different cbd concentrations in its hemp oil.

Operational Statement

"We are very pleased with our overall quarterly results. It's a testament to the team's hard work, diligence and preparation," said Michelle Sides, Chairman of Medical Marijuana Inc.

Financial Tables


Three months ended

Sept. 30, 2011

Three months ended

Dec. 31, 2011

Three months ended

Mar. 31, 2012

Three months ended

Jun. 30, 2012

Three months ended

Sept. 30, 2012

Revenue

$198,813

$430,140

$1,788,445

$2,403,624

$3,001,902

Assets

$1,443,251

$1,948,165

$6,356,301

$7,908,677

$8,131,147

Debt

$14,879

$26,785

$101,778

$156,778

$585,437

Net Income

($1,067,473)

($62,711)

$1,208,136

$1,471,596

$1,193,937







FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections.  This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

About Medical Marijuana, Inc.

Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit.  We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value.  For more information, please visit the company's website at:  www.MedicalMarijuanaInc.com.

Corporate Contact:
Medical Marijuana, Inc.
Toll Free: 888-OTC-MJNA (888-682-6562)
www.medicalmarijuanainc.com   
www.facebook.com/mjnainc

Investor Relations Contact:
Stuart T. Smith
SmallCapVoice.Com, Inc.
P. 512-267-2430      
F. 512-267-2530
Skype: SmallCapVoice.com
AIM: SmallCapVoice7

SOURCE Medical Marijuana, Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES